Related Experiment Videos
Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike
C Di Simone1, M A Zandonatti, M J Buchmeier
1Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037.
Abstract:
Membrane fusion activity of the glycoprotein (GP) complex of LCMV was determined using the R18 fluorescent dequenching assay. Utilization of an endosomal entry route by LCMV and acidic activation of the membrane fusion activity were indicated by the inhibition of LCMV infection at an early stage by the lysosomal weak base chloroquine and the ionophore monensin. When LCMV was mixed with R18-labeled liposomes with a lipid composition mimicking that of the endosome, dequenching occurred only at acidic pH (< or = 6.0). The measured dequenching was inhibited by protease treatment of the LCMV, indicative of protein-mediated membrane fusion. The initial rate of fusion was measured at pH values between 5.3 and 7.0 and was found to decrease rapidly and linearly between pH 5.3 (0.177%/sec) and pH 6.0 (0.027%/sec). Binding and fusion of R18-labeled LCMV with BHK cells were also examined. No difference was found between R18-labeled and unlabeled LCMV in binding to or infection of BHK cells. Dequenching was observed in labeled LCMV endocytosed by BHK cells. With BHK cells neither LCMV fusion with the plasma membrane nor LCMV-induced cell-cell fusion was observed, even under acidic conditions, and examination of the sequence of LCMV GP did not reveal a likely candidate sequence for a "fusion peptide." The binding of conformationally dependent monoclonal antibodies to GP was measured at neutral and acidic pH in order to seek evidence of pH-dependent conformational change in GP. Dissociation of the GP-1 from the complex was measured by sucrose gradients run on purified virus. These experiments revealed that after exposure to acid pH the LCMV glycoprotein spike complex underwent irreversible conformational change in which GP-1 was dissociated from the virion, conformational epitopes on GP-1 were lost, and sequestered epitopes on GP-2 became exposed. Further, LCMV infectivity was irreversibly inactivated by exposure to acidic pH (< 6.0), likely due to the loss of GP-1 and conformation changes in GP-2.
Insights
Lymphocytic choriomeningitis virus (LCMV) uses an endosomal pathway for infection, requiring acidic pH for membrane fusion mediated by its glycoprotein complex. This process involves irreversible conformational changes in the glycoprotein, leading to viral inactivation.
Area of Science:
- Virology
- Cell Biology
- Biochemistry
Background:
- Lymphocytic choriomeningitis virus (LCMV) is an important human pathogen.
- Understanding LCMV entry mechanisms is crucial for developing antiviral strategies.
Purpose of the Study:
- To investigate the membrane fusion activity of the LCMV glycoprotein (GP) complex.
- To determine the role of endosomal entry and acidic pH in LCMV infection.
Main Methods:
- R18 fluorescent dequenching assay to measure membrane fusion.
- Inhibition studies using chloroquine and monensin.
- Analysis of glycoprotein conformational changes using monoclonal antibodies and sucrose gradients.
Main Results:
- LCMV utilizes an endosomal entry route activated by acidic pH (<6.0).
- Membrane fusion is protein-mediated and occurs within endosomes.
- Acidic pH induces irreversible conformational changes in the LCMV GP complex, including GP-1 dissociation and GP-2 epitope exposure, leading to loss of infectivity.
Conclusions:
- LCMV infection is dependent on endosomal acidification for membrane fusion.
- The LCMV glycoprotein undergoes significant pH-dependent conformational changes essential for viral entry.
- These findings provide insights into LCMV pathogenesis and potential therapeutic targets.